Ethoxy Propanol
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Avastin (Bevacizumab) Biosimilars Market Research Report 2024
1 Avastin (Bevacizumab) Biosimilars Market Overview
1.1 Product Overview and Scope of Avastin (Bevacizumab) Biosimilars
1.2 Avastin (Bevacizumab) Biosimilars Segment by Type
1.2.1 Global Avastin (Bevacizumab) Biosimilars Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Cancers
1.2.3 AMD
1.3 Avastin (Bevacizumab) Biosimilars Segment by Application
1.3.1 Global Avastin (Bevacizumab) Biosimilars Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Avastin (Bevacizumab) Biosimilars Market Size Estimates and Forecasts
1.4.1 Global Avastin (Bevacizumab) Biosimilars Revenue 2017-2028
1.4.2 Global Avastin (Bevacizumab) Biosimilars Sales 2017-2028
1.4.3 Avastin (Bevacizumab) Biosimilars Market Size by Region: 2017 Versus 2021 Versus 2028
2 Avastin (Bevacizumab) Biosimilars Market Competition by Manufacturers
2.1 Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Manufacturers (2017-2022)
2.2 Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Avastin (Bevacizumab) Biosimilars Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Avastin (Bevacizumab) Biosimilars Manufacturing Sites, Area Served, Product Type
2.5 Avastin (Bevacizumab) Biosimilars Market Competitive Situation and Trends
2.5.1 Avastin (Bevacizumab) Biosimilars Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Avastin (Bevacizumab) Biosimilars Players Market Share by Revenue
2.5.3 Global Avastin (Bevacizumab) Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Avastin (Bevacizumab) Biosimilars Retrospective Market Scenario by Region
3.1 Global Avastin (Bevacizumab) Biosimilars Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Avastin (Bevacizumab) Biosimilars Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Avastin (Bevacizumab) Biosimilars Market Facts & Figures by Country
3.3.1 North America Avastin (Bevacizumab) Biosimilars Sales by Country
3.3.2 North America Avastin (Bevacizumab) Biosimilars Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Avastin (Bevacizumab) Biosimilars Market Facts & Figures by Country
3.4.1 Europe Avastin (Bevacizumab) Biosimilars Sales by Country
3.4.2 Europe Avastin (Bevacizumab) Biosimilars Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Avastin (Bevacizumab) Biosimilars Market Facts & Figures by Region
3.5.1 Asia Pacific Avastin (Bevacizumab) Biosimilars Sales by Region
3.5.2 Asia Pacific Avastin (Bevacizumab) Biosimilars Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Avastin (Bevacizumab) Biosimilars Market Facts & Figures by Country
3.6.1 Latin America Avastin (Bevacizumab) Biosimilars Sales by Country
3.6.2 Latin America Avastin (Bevacizumab) Biosimilars Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Avastin (Bevacizumab) Biosimilars Market Facts & Figures by Country
3.7.1 Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales by Country
3.7.2 Middle East and Africa Avastin (Bevacizumab) Biosimilars Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Avastin (Bevacizumab) Biosimilars Historic Market Analysis by Type
4.1 Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Type (2017-2022)
4.2 Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Type (2017-2022)
4.3 Global Avastin (Bevacizumab) Biosimilars Price by Type (2017-2022)
5 Global Avastin (Bevacizumab) Biosimilars Historic Market Analysis by Application
5.1 Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Application (2017-2022)
5.2 Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Application (2017-2022)
5.3 Global Avastin (Bevacizumab) Biosimilars Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Corporation Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Roche Avastin (Bevacizumab) Biosimilars Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Genentech
6.2.1 Genentech Corporation Information
6.2.2 Genentech Description and Business Overview
6.2.3 Genentech Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Genentech Avastin (Bevacizumab) Biosimilars Product Portfolio
6.2.5 Genentech Recent Developments/Updates
6.3 Pfizer
6.3.1 Pfizer Corporation Information
6.3.2 Pfizer Description and Business Overview
6.3.3 Pfizer Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Pfizer Avastin (Bevacizumab) Biosimilars Product Portfolio
6.3.5 Pfizer Recent Developments/Updates
6.4 Sartorius
6.4.1 Sartorius Corporation Information
6.4.2 Sartorius Description and Business Overview
6.4.3 Sartorius Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sartorius Avastin (Bevacizumab) Biosimilars Product Portfolio
6.4.5 Sartorius Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Eli Lilly Avastin (Bevacizumab) Biosimilars Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 Bayer
6.6.1 Bayer Corporation Information
6.6.2 Bayer Description and Business Overview
6.6.3 Bayer Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Bayer Avastin (Bevacizumab) Biosimilars Product Portfolio
6.6.5 Bayer Recent Developments/Updates
6.7 Amgen
6.6.1 Amgen Corporation Information
6.6.2 Amgen Description and Business Overview
6.6.3 Amgen Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Amgen Avastin (Bevacizumab) Biosimilars Product Portfolio
6.7.5 Amgen Recent Developments/Updates
6.8 PlantForm
6.8.1 PlantForm Corporation Information
6.8.2 PlantForm Description and Business Overview
6.8.3 PlantForm Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.8.4 PlantForm Avastin (Bevacizumab) Biosimilars Product Portfolio
6.8.5 PlantForm Recent Developments/Updates
6.9 PharmaPraxis
6.9.1 PharmaPraxis Corporation Information
6.9.2 PharmaPraxis Description and Business Overview
6.9.3 PharmaPraxis Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.9.4 PharmaPraxis Avastin (Bevacizumab) Biosimilars Product Portfolio
6.9.5 PharmaPraxis Recent Developments/Updates
6.10 Samsung Bioepis
6.10.1 Samsung Bioepis Corporation Information
6.10.2 Samsung Bioepis Description and Business Overview
6.10.3 Samsung Bioepis Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Samsung Bioepis Avastin (Bevacizumab) Biosimilars Product Portfolio
6.10.5 Samsung Bioepis Recent Developments/Updates
6.11 Centus
6.11.1 Centus Corporation Information
6.11.2 Centus Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.11.3 Centus Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Centus Avastin (Bevacizumab) Biosimilars Product Portfolio
6.11.5 Centus Recent Developments/Updates
6.12 Cadila Pharmaceuticals
6.12.1 Cadila Pharmaceuticals Corporation Information
6.12.2 Cadila Pharmaceuticals Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.12.3 Cadila Pharmaceuticals Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Cadila Pharmaceuticals Avastin (Bevacizumab) Biosimilars Product Portfolio
6.12.5 Cadila Pharmaceuticals Recent Developments/Updates
6.13 Dr Reddy's
6.13.1 Dr Reddy's Corporation Information
6.13.2 Dr Reddy's Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.13.3 Dr Reddy's Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Dr Reddy's Avastin (Bevacizumab) Biosimilars Product Portfolio
6.13.5 Dr Reddy's Recent Developments/Updates
6.14 Aurobindo Pharma
6.14.1 Aurobindo Pharma Corporation Information
6.14.2 Aurobindo Pharma Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.14.3 Aurobindo Pharma Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Aurobindo Pharma Avastin (Bevacizumab) Biosimilars Product Portfolio
6.14.5 Aurobindo Pharma Recent Developments/Updates
6.15 Biocad
6.15.1 Biocad Corporation Information
6.15.2 Biocad Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.15.3 Biocad Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Biocad Avastin (Bevacizumab) Biosimilars Product Portfolio
6.15.5 Biocad Recent Developments/Updates
6.16 MAbxience
6.16.1 MAbxience Corporation Information
6.16.2 MAbxience Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.16.3 MAbxience Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.16.4 MAbxience Avastin (Bevacizumab) Biosimilars Product Portfolio
6.16.5 MAbxience Recent Developments/Updates
6.17 Hetero
6.17.1 Hetero Corporation Information
6.17.2 Hetero Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.17.3 Hetero Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Hetero Avastin (Bevacizumab) Biosimilars Product Portfolio
6.17.5 Hetero Recent Developments/Updates
6.18 Biocon
6.18.1 Biocon Corporation Information
6.18.2 Biocon Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.18.3 Biocon Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Biocon Avastin (Bevacizumab) Biosimilars Product Portfolio
6.18.5 Biocon Recent Developments/Updates
6.19 Kirin Biologics
6.19.1 Kirin Biologics Corporation Information
6.19.2 Kirin Biologics Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.19.3 Kirin Biologics Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Kirin Biologics Avastin (Bevacizumab) Biosimilars Product Portfolio
6.19.5 Kirin Biologics Recent Developments/Updates
6.20 Mylan
6.20.1 Mylan Corporation Information
6.20.2 Mylan Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.20.3 Mylan Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.20.4 Mylan Avastin (Bevacizumab) Biosimilars Product Portfolio
6.20.5 Mylan Recent Developments/Updates
6.21 BeiGene
6.21.1 BeiGene Corporation Information
6.21.2 BeiGene Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.21.3 BeiGene Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.21.4 BeiGene Avastin (Bevacizumab) Biosimilars Product Portfolio
6.21.5 BeiGene Recent Developments/Updates
6.22 Innovent
6.22.1 Innovent Corporation Information
6.22.2 Innovent Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.22.3 Innovent Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.22.4 Innovent Avastin (Bevacizumab) Biosimilars Product Portfolio
6.22.5 Innovent Recent Developments/Updates
6.23 Qilu Pharmaceutical
6.23.1 Qilu Pharmaceutical Corporation Information
6.23.2 Qilu Pharmaceutical Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.23.3 Qilu Pharmaceutical Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.23.4 Qilu Pharmaceutical Avastin (Bevacizumab) Biosimilars Product Portfolio
6.23.5 Qilu Pharmaceutical Recent Developments/Updates
6.24 Hengrui Pharmaceuticals
6.24.1 Hengrui Pharmaceuticals Corporation Information
6.24.2 Hengrui Pharmaceuticals Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.24.3 Hengrui Pharmaceuticals Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.24.4 Hengrui Pharmaceuticals Avastin (Bevacizumab) Biosimilars Product Portfolio
6.24.5 Hengrui Pharmaceuticals Recent Developments/Updates
6.25 Hisun Pharmaceutical
6.25.1 Hisun Pharmaceutical Corporation Information
6.25.2 Hisun Pharmaceutical Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.25.3 Hisun Pharmaceutical Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.25.4 Hisun Pharmaceutical Avastin (Bevacizumab) Biosimilars Product Portfolio
6.25.5 Hisun Pharmaceutical Recent Developments/Updates
6.26 TOT BIOPHARM
6.26.1 TOT BIOPHARM Corporation Information
6.26.2 TOT BIOPHARM Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.26.3 TOT BIOPHARM Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.26.4 TOT BIOPHARM Avastin (Bevacizumab) Biosimilars Product Portfolio
6.26.5 TOT BIOPHARM Recent Developments/Updates
6.27 Luye Pharmaceutical
6.27.1 Luye Pharmaceutical Corporation Information
6.27.2 Luye Pharmaceutical Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.27.3 Luye Pharmaceutical Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.27.4 Luye Pharmaceutical Avastin (Bevacizumab) Biosimilars Product Portfolio
6.27.5 Luye Pharmaceutical Recent Developments/Updates
6.28 Henlius
6.28.1 Henlius Corporation Information
6.28.2 Henlius Avastin (Bevacizumab) Biosimilars Description and Business Overview
6.28.3 Henlius Avastin (Bevacizumab) Biosimilars Sales, Revenue and Gross Margin (2017-2022)
6.28.4 Henlius Avastin (Bevacizumab) Biosimilars Product Portfolio
6.28.5 Henlius Recent Developments/Updates
7 Avastin (Bevacizumab) Biosimilars Manufacturing Cost Analysis
7.1 Avastin (Bevacizumab) Biosimilars Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Avastin (Bevacizumab) Biosimilars
7.4 Avastin (Bevacizumab) Biosimilars Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Avastin (Bevacizumab) Biosimilars Distributors List
8.3 Avastin (Bevacizumab) Biosimilars Customers
9 Avastin (Bevacizumab) Biosimilars Market Dynamics
9.1 Avastin (Bevacizumab) Biosimilars Industry Trends
9.2 Avastin (Bevacizumab) Biosimilars Market Drivers
9.3 Avastin (Bevacizumab) Biosimilars Market Challenges
9.4 Avastin (Bevacizumab) Biosimilars Market Restraints
10 Global Market Forecast
10.1 Avastin (Bevacizumab) Biosimilars Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Avastin (Bevacizumab) Biosimilars by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Avastin (Bevacizumab) Biosimilars by Type (2023-2028)
10.2 Avastin (Bevacizumab) Biosimilars Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Avastin (Bevacizumab) Biosimilars by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Avastin (Bevacizumab) Biosimilars by Application (2023-2028)
10.3 Avastin (Bevacizumab) Biosimilars Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Avastin (Bevacizumab) Biosimilars by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Avastin (Bevacizumab) Biosimilars by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Avastin (Bevacizumab) Biosimilars Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Avastin (Bevacizumab) Biosimilars Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Avastin (Bevacizumab) Biosimilars Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Avastin (Bevacizumab) Biosimilars Market Competitive Situation by Manufacturers in 2021
Table 5. Global Avastin (Bevacizumab) Biosimilars Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Avastin (Bevacizumab) Biosimilars Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Avastin (Bevacizumab) Biosimilars Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Avastin (Bevacizumab) Biosimilars Average Price (K USD/K Units) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Avastin (Bevacizumab) Biosimilars Manufacturing Sites and Area Served
Table 11. Manufacturers Avastin (Bevacizumab) Biosimilars Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Avastin (Bevacizumab) Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Avastin (Bevacizumab) Biosimilars as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Avastin (Bevacizumab) Biosimilars Sales by Region (2017-2022) & (K Units)
Table 16. Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Region (2017-2022)
Table 17. Global Avastin (Bevacizumab) Biosimilars Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Region (2017-2022)
Table 19. North America Avastin (Bevacizumab) Biosimilars Sales by Country (2017-2022) & (K Units)
Table 20. North America Avastin (Bevacizumab) Biosimilars Sales Market Share by Country (2017-2022)
Table 21. North America Avastin (Bevacizumab) Biosimilars Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Avastin (Bevacizumab) Biosimilars Revenue Market Share by Country (2017-2022)
Table 23. Europe Avastin (Bevacizumab) Biosimilars Sales by Country (2017-2022) & (K Units)
Table 24. Europe Avastin (Bevacizumab) Biosimilars Sales Market Share by Country (2017-2022)
Table 25. Europe Avastin (Bevacizumab) Biosimilars Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Avastin (Bevacizumab) Biosimilars Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Avastin (Bevacizumab) Biosimilars Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Avastin (Bevacizumab) Biosimilars Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Avastin (Bevacizumab) Biosimilars Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Avastin (Bevacizumab) Biosimilars Revenue Market Share by Region (2017-2022)
Table 31. Latin America Avastin (Bevacizumab) Biosimilars Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Avastin (Bevacizumab) Biosimilars Sales Market Share by Country (2017-2022)
Table 33. Latin America Avastin (Bevacizumab) Biosimilars Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Avastin (Bevacizumab) Biosimilars Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Avastin (Bevacizumab) Biosimilars Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Avastin (Bevacizumab) Biosimilars Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Avastin (Bevacizumab) Biosimilars Revenue Market Share by Country (2017-2022)
Table 39. Global Avastin (Bevacizumab) Biosimilars Sales by Type (2017-2022) & (K Units)
Table 40. Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Type (2017-2022)
Table 41. Global Avastin (Bevacizumab) Biosimilars Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Avastin (Bevacizumab) Biosimilars Revenue Share by Type (2017-2022)
Table 43. Global Avastin (Bevacizumab) Biosimilars Price by Type (2017-2022) & (K USD/K Units)
Table 44. Global Avastin (Bevacizumab) Biosimilars Sales (K Units) by Application (2017-2022)
Table 45. Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Application (2017-2022)
Table 46. Global Avastin (Bevacizumab) Biosimilars Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Avastin (Bevacizumab) Biosimilars Revenue Share by Application (2017-2022)
Table 48. Global Avastin (Bevacizumab) Biosimilars Price by Application (2017-2022) & (K USD/K Units)
Table 49. Roche Corporation Information
Table 50. Roche Description and Business Overview
Table 51. Roche Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 52. Roche Avastin (Bevacizumab) Biosimilars Product
Table 53. Roche Recent Developments/Updates
Table 54. Genentech Corporation Information
Table 55. Genentech Description and Business Overview
Table 56. Genentech Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 57. Genentech Avastin (Bevacizumab) Biosimilars Product
Table 58. Genentech Recent Developments/Updates
Table 59. Pfizer Corporation Information
Table 60. Pfizer Description and Business Overview
Table 61. Pfizer Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 62. Pfizer Avastin (Bevacizumab) Biosimilars Product
Table 63. Pfizer Recent Developments/Updates
Table 64. Sartorius Corporation Information
Table 65. Sartorius Description and Business Overview
Table 66. Sartorius Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 67. Sartorius Avastin (Bevacizumab) Biosimilars Product
Table 68. Sartorius Recent Developments/Updates
Table 69. Eli Lilly Corporation Information
Table 70. Eli Lilly Description and Business Overview
Table 71. Eli Lilly Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 72. Eli Lilly Avastin (Bevacizumab) Biosimilars Product
Table 73. Eli Lilly Recent Developments/Updates
Table 74. Bayer Corporation Information
Table 75. Bayer Description and Business Overview
Table 76. Bayer Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 77. Bayer Avastin (Bevacizumab) Biosimilars Product
Table 78. Bayer Recent Developments/Updates
Table 79. Amgen Corporation Information
Table 80. Amgen Description and Business Overview
Table 81. Amgen Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 82. Amgen Avastin (Bevacizumab) Biosimilars Product
Table 83. Amgen Recent Developments/Updates
Table 84. PlantForm Corporation Information
Table 85. PlantForm Description and Business Overview
Table 86. PlantForm Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 87. PlantForm Avastin (Bevacizumab) Biosimilars Product
Table 88. PlantForm Recent Developments/Updates
Table 89. PharmaPraxis Corporation Information
Table 90. PharmaPraxis Description and Business Overview
Table 91. PharmaPraxis Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 92. PharmaPraxis Avastin (Bevacizumab) Biosimilars Product
Table 93. PharmaPraxis Recent Developments/Updates
Table 94. Samsung Bioepis Corporation Information
Table 95. Samsung Bioepis Description and Business Overview
Table 96. Samsung Bioepis Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 97. Samsung Bioepis Avastin (Bevacizumab) Biosimilars Product
Table 98. Samsung Bioepis Recent Developments/Updates
Table 99. Centus Corporation Information
Table 100. Centus Description and Business Overview
Table 101. Centus Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 102. Centus Avastin (Bevacizumab) Biosimilars Product
Table 103. Centus Recent Developments/Updates
Table 104. Cadila Pharmaceuticals Corporation Information
Table 105. Cadila Pharmaceuticals Description and Business Overview
Table 106. Cadila Pharmaceuticals Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 107. Cadila Pharmaceuticals Avastin (Bevacizumab) Biosimilars Product
Table 108. Cadila Pharmaceuticals Recent Developments/Updates
Table 109. Dr Reddy's Corporation Information
Table 110. Dr Reddy's Description and Business Overview
Table 111. Dr Reddy's Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 112. Dr Reddy's Avastin (Bevacizumab) Biosimilars Product
Table 113. Dr Reddy's Recent Developments/Updates
Table 114. Aurobindo Pharma Corporation Information
Table 115. Aurobindo Pharma Description and Business Overview
Table 116. Aurobindo Pharma Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 117. Aurobindo Pharma Avastin (Bevacizumab) Biosimilars Product
Table 118. Aurobindo Pharma Recent Developments/Updates
Table 119. Biocad Corporation Information
Table 120. Biocad Description and Business Overview
Table 121. Biocad Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 122. Biocad Avastin (Bevacizumab) Biosimilars Product
Table 123. Biocad Recent Developments/Updates
Table 124. MAbxience Corporation Information
Table 125. MAbxience Description and Business Overview
Table 126. MAbxience Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 127. MAbxience Avastin (Bevacizumab) Biosimilars Product
Table 128. MAbxience Recent Developments/Updates
Table 129. Hetero Corporation Information
Table 130. Hetero Description and Business Overview
Table 131. Hetero Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 132. Hetero Avastin (Bevacizumab) Biosimilars Product
Table 133. Hetero Recent Developments/Updates
Table 134. Biocon Corporation Information
Table 135. Biocon Description and Business Overview
Table 136. Biocon Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 137. Biocon Avastin (Bevacizumab) Biosimilars Product
Table 138. Biocon Recent Developments/Updates
Table 139. Kirin Biologics Corporation Information
Table 140. Kirin Biologics Description and Business Overview
Table 141. Kirin Biologics Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 142. Kirin Biologics Avastin (Bevacizumab) Biosimilars Product
Table 143. Kirin Biologics Recent Developments/Updates
Table 144. Mylan Corporation Information
Table 145. Mylan Description and Business Overview
Table 146. Mylan Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 147. Mylan Avastin (Bevacizumab) Biosimilars Product
Table 148. Mylan Recent Developments/Updates
Table 149. BeiGene Corporation Information
Table 150. BeiGene Description and Business Overview
Table 151. BeiGene Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 152. BeiGene Avastin (Bevacizumab) Biosimilars Product
Table 153. BeiGene Recent Developments/Updates
Table 154. Innovent Corporation Information
Table 155. Innovent Description and Business Overview
Table 156. Innovent Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 157. Innovent Avastin (Bevacizumab) Biosimilars Product
Table 158. Innovent Recent Developments/Updates
Table 159. Qilu Pharmaceutical Corporation Information
Table 160. Qilu Pharmaceutical Description and Business Overview
Table 161. Qilu Pharmaceutical Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 162. Qilu Pharmaceutical Avastin (Bevacizumab) Biosimilars Product
Table 163. Qilu Pharmaceutical Recent Developments/Updates
Table 164. Hengrui Pharmaceuticals Corporation Information
Table 165. Hengrui Pharmaceuticals Description and Business Overview
Table 166. Hengrui Pharmaceuticals Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 167. Hengrui Pharmaceuticals Avastin (Bevacizumab) Biosimilars Product
Table 168. Hengrui Pharmaceuticals Recent Developments/Updates
Table 169. Hisun Pharmaceutical Corporation Information
Table 170. Hisun Pharmaceutical Description and Business Overview
Table 171. Hisun Pharmaceutical Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 172. Hisun Pharmaceutical Avastin (Bevacizumab) Biosimilars Product
Table 173. Hisun Pharmaceutical Recent Developments/Updates
Table 174. TOT BIOPHARM Corporation Information
Table 175. TOT BIOPHARM Description and Business Overview
Table 176. TOT BIOPHARM Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 177. TOT BIOPHARM Avastin (Bevacizumab) Biosimilars Product
Table 178. TOT BIOPHARM Recent Developments/Updates
Table 179. Luye Pharmaceutical Corporation Information
Table 180. Luye Pharmaceutical Description and Business Overview
Table 181. Luye Pharmaceutical Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 182. Luye Pharmaceutical Avastin (Bevacizumab) Biosimilars Product
Table 183. Luye Pharmaceutical Recent Developments/Updates
Table 184. Henlius Corporation Information
Table 185. Henlius Description and Business Overview
Table 186. Henlius Avastin (Bevacizumab) Biosimilars Sales (K Units), Revenue (US$ Million), Price (K USD/K Units) and Gross Margin (2017-2022)
Table 187. Henlius Avastin (Bevacizumab) Biosimilars Product
Table 188. Henlius Recent Developments/Updates
Table 189. Production Base and Market Concentration Rate of Raw Material
Table 190. Key Suppliers of Raw Materials
Table 191. Avastin (Bevacizumab) Biosimilars Distributors List
Table 192. Avastin (Bevacizumab) Biosimilars Customers List
Table 193. Avastin (Bevacizumab) Biosimilars Market Trends
Table 194. Avastin (Bevacizumab) Biosimilars Market Drivers
Table 195. Avastin (Bevacizumab) Biosimilars Market Challenges
Table 196. Avastin (Bevacizumab) Biosimilars Market Restraints
Table 197. Global Avastin (Bevacizumab) Biosimilars Sales Forecast by Type (2023-2028) & (K Units)
Table 198. Global Avastin (Bevacizumab) Biosimilars Sales Market Share Forecast by Type (2023-2028)
Table 199. Global Avastin (Bevacizumab) Biosimilars Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 200. Global Avastin (Bevacizumab) Biosimilars Revenue Market Share Forecast by Type (2023-2028)
Table 201. Global Avastin (Bevacizumab) Biosimilars Sales Forecast by Application (2023-2028) & (K Units)
Table 202. Global Avastin (Bevacizumab) Biosimilars Sales Market Share Forecast by Application (2023-2028)
Table 203. Global Avastin (Bevacizumab) Biosimilars Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 204. Global Avastin (Bevacizumab) Biosimilars Revenue Market Share Forecast by Application (2023-2028)
Table 205. Global Avastin (Bevacizumab) Biosimilars Sales Forecast by Region (2023-2028) & (K Units)
Table 206. Global Avastin (Bevacizumab) Biosimilars Sales Market Share Forecast by Region (2023-2028)
Table 207. Global Avastin (Bevacizumab) Biosimilars Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 208. Global Avastin (Bevacizumab) Biosimilars Revenue Market Share Forecast by Region (2023-2028)
Table 209. Research Programs/Design for This Report
Table 210. Key Data Information from Secondary Sources
Table 211. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Avastin (Bevacizumab) Biosimilars
Figure 2. Global Avastin (Bevacizumab) Biosimilars Market Share by Type in 2021 & 2028
Figure 3. Cancers Product Picture
Figure 4. AMD Product Picture
Figure 5. Global Avastin (Bevacizumab) Biosimilars Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Global Avastin (Bevacizumab) Biosimilars Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Avastin (Bevacizumab) Biosimilars Market Size (2017-2028) & (US$ Million)
Figure 11. Global Avastin (Bevacizumab) Biosimilars Sales (2017-2028) & (K Units)
Figure 12. Avastin (Bevacizumab) Biosimilars Sales Share by Manufacturers in 2021
Figure 13. Global Avastin (Bevacizumab) Biosimilars Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Avastin (Bevacizumab) Biosimilars Players: Market Share by Revenue in 2021
Figure 15. Avastin (Bevacizumab) Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Region (2017-2022)
Figure 17. Global Avastin (Bevacizumab) Biosimilars Sales Market Share by Region in 2021
Figure 18. Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Region (2017-2022)
Figure 19. Global Avastin (Bevacizumab) Biosimilars Revenue Market Share by Region in 2021
Figure 20. United States Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Taiwan Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Avastin (Bevacizumab) Biosimilars Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Avastin (Bevacizumab) Biosimilars by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Avastin (Bevacizumab) Biosimilars
Figure 44. Manufacturing Process Analysis of Avastin (Bevacizumab) Biosimilars
Figure 45. Avastin (Bevacizumab) Biosimilars Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Roche Genentech Pfizer Sartorius Eli Lilly Bayer Amgen PlantForm PharmaPraxis Samsung Bioepis Centus Cadila Pharmaceuticals Dr Reddy's Aurobindo Pharma Biocad MAbxience Hetero Biocon Kirin Biologics Mylan BeiGene Innovent Qilu Pharmaceutical Hengrui Pharmaceuticals Hisun Pharmaceutical TOT BIOPHARM Luye Pharmaceutical Henlius